A detailed history of Tompkins Financial Corp transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Tompkins Financial Corp holds 50 shares of JAZZ stock, worth $5,522. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 150 66.67%
Holding current value
$5,522
Previous $16,000 68.75%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$100.57 - $116.37 $10,057 - $11,637
-100 Reduced 66.67%
50 $5,000
Q2 2024

Jul 17, 2024

BUY
$103.94 - $118.98 $15,591 - $17,847
150 New
150 $16,000
Q1 2021

Jun 09, 2021

SELL
$150.19 - $173.5 $750 - $867
-5 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$140.71 - $165.05 $703 - $825
5 New
5 $1,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $6.92B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Tompkins Financial Corp Portfolio

Follow Tompkins Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tompkins Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Tompkins Financial Corp with notifications on news.